Ichiro Abe. “Efficacy and Safety of Low-Dose Ipragliflozin, a Selective Sodium Glucose Transporter 2 Inhibitor, in Patients With Type 2 Diabetes Mellitus”. International Journal of Allied Medical Sciences and Clinical Research 4, no. 3 (August 6, 2020): 376–382. Accessed June 24, 2024. https://ijamscr.com/ijamscr/article/view/283.